New targeted drug offers hope for rare bile duct cancer
NCT ID NCT06607302
First seen Jan 05, 2026 · Last updated Jun 18, 2026 · Updated 25 times
Summary
This study looks at how well the drug ivosidenib works for people with advanced bile duct cancer that has a specific IDH1 gene mutation. About 100 adults in Germany who have already tried at least one other cancer treatment will take ivosidenib as prescribed. Researchers will track how long the cancer stays under control, quality of life, and side effects in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caritas Krankenhaus Bad Mergentheim
RECRUITINGBad Mergentheim, Germany
Contact
-
Hämatologisch-Onkologische Schwerpunktpraxis in Bad Liebenwerda
RECRUITINGBad Liebenwerda, Germany
Contact
-
Medizinisches Versorgungszentrum Mönchengladbach
RECRUITINGMönchengladbach, Germany
Contact
-
Onkologie Hannover
RECRUITINGHanover, Germany
Contact
-
Onkologie Hof
RECRUITINGHof, Germany
Contact
-
Onkologisches Versorgungszentrum Berlin MVZ
RECRUITINGBerlin, Germany
Contact
-
ze:roPRAXEN MVZ für Innere Medizin
RECRUITINGWeinheim, Germany
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.